Whole Genome and Exome Sequencing Market
Whole Genome and Exome Sequencing Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Whole Genome and Exome Sequencing Market Size and Growth
The Whole Genome and Exome Sequencing market is experiencing significant growth, driven by advancements in technology and increasing demand for personalized medicine. The global market size was valued at approximately $7 billion in 2022 and is projected to reach over $14 billion by 2028, reflecting a robust CAGR due to expanding applications in research and clinical settings. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Eurofins Scientific SE
◍ Agilent Technologies, Inc
◍ Beijing Genomics Institute (BGI)
◍ Hoffmann-La Roche Ltd
◍ Bio-Rad Laboratories, Inc
◍ GENEWIZ, Inc
◍ Illumina, Inc
◍ Laboratory Corporation of America Holdings
◍ Novogene Corporation
◍ Oxford Nanopore Technologies, Inc
◍ Pacific Biosciences of California, Inc
◍ QIAGEN N.V
◍ Thermo Fisher Scientific Inc
◍ Cytiva
The Whole Genome and Exome Sequencing Market is competitive, featuring companies like Illumina and Thermo Fisher Scientific, which innovate sequencing technologies. Others, such as BGI and Roche, offer comprehensive genomic services. These firms contribute to market growth through research advancements and expanded accessibility, enhancing diagnostics and personalized medicine.
**Sales Revenue Highlights:**
- Illumina: $3.46 billion (2022)
- Thermo Fisher: $40.96 billion (2022)
- Agilent Technologies: $5.62 billion (2022)
Request Sample Report
Market Segmentation
By Application
◍ Hospitals and Clinics
◍ Pharmaceutical and Biotechnology Companies
◍ Diagnostic Labs
◍ Research Centres, Academia and Government Institutes
◍ Others
Request Sample Report
By Product
Kits
Instruments
$ 43.01 Billion
Request Sample Report
